Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn’s disease: 2-year results from the U-ENDURE Long-Term Extension studyEdward V. Loftus, Irina Blumenstein, Édouard Louis et al.|Journal of Crohn s and Colitis|2025Cited by 8